Cargando…
Arterial Remodelling in Chronic Kidney Disease: Impact of Uraemic Toxins and New Pharmacological Approaches
Chronic kidney disease (CKD) is a major public health concern that affects around 10 percent of the world’s population. The severity of CKD is mainly due to the high prevalence of cardiovascular (CV) complications in this population. The aim of this review is to describe the arterial remodelling ass...
Autores principales: | Foudi, Nabil, Palayer, Maeva, Briet, Marie, Garnier, Anne-Sophie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432213/ https://www.ncbi.nlm.nih.gov/pubmed/34501251 http://dx.doi.org/10.3390/jcm10173803 |
Ejemplares similares
-
From old uraemic toxins to new uraemic toxins: place of ‘omics’
por: Massy, Ziad A, et al.
Publicado: (2018) -
Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?
por: Liabeuf, Sophie, et al.
Publicado: (2021) -
A history of uraemic toxicity and of the European Uraemic Toxin Work Group (EUTox)
por: Vanholder, Raymond, et al.
Publicado: (2021) -
Potential interactions between uraemic toxins and drugs: an application in kidney transplant recipients treated with calcineurin inhibitors
por: André, Camille, et al.
Publicado: (2021) -
Dietary Fibre Intake Is Associated with Serum Levels of Uraemic Toxins in Children with Chronic Kidney Disease
por: El Amouri, Amina, et al.
Publicado: (2021)